Advertisements



Citi starts Sirius with Neutral rating, $15 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 11th, 2019

Citi starts Zogenix with Neutral rating, $27 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 6th, 2020

Citi starts Zillow with Neutral rating, $46 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 9th, 2019

Citi starts Sage Therapeutics with Buy rating, $71 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 6th, 2020

Citi starts Liberty Broadband with a Buy rating, $125 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2019

Nomura Instinet starts Tenable with Neutral rating, $30 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2019

Citi starts Amcor with Bu rating, $13 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 20th, 2019

Citi starts Pluralsight with Buy rating, $42 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

Citi starts Akebia Therapeutics with Neutral, $9 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 20th, 2019

Citi starts Instructure with a Buy rating, $55 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2018

Citi starts Cision with a Buy rating, $21 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 2nd, 2018

Huya stock falls after Goldman Sachs starts coverage with neutral rating

Shares of Chinese game-streaming company Huya Inc. are down 1% in Friday morning trading after Goldman Sachs analyst Piyush Mubayi initiated coverage of the stock with a neutral rating and $34 price target. "We believe the .....»»

Category: topSource: marketwatchAug 3rd, 2018

Citi starts Rigel Pharmaceuticals with Buy rating, $8.50 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 27th, 2018

Citi starts Dicerna with Buy rating, $27 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Goldman starts DocuSign with Neutral rating, $45 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play

Johnson & Johnson's Q1 earnings report on April 16 is expected to show $2.64 EPS and $21.4 billion in revenues. Technical analysis shows a bearish trend but analysts have a neutral rating with a $171.95 price target and potential 37.15% upside. read more.....»»

Category: blogSource: benzingaApr 15th, 2024

B. Riley starts Forte Biosciences with Buy rating, $73 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2021

BofA starts Frontier Group at Neutral with $22 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 26th, 2021

BofA starts Bunge at Neutral with $88 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 21st, 2021

Deutsche starts Crowdstrike with Buy rating, $265 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2021

Canaccord starts Parts iD with Buy rating, $12 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 7th, 2021